• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: FinlandChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
EoE Pocket Guide
Gastroenterology
5 min
interactivity

EoE Pocket Guide

Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology
Dermatology
25 min
expert video

Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology

Shared and Distinct: The Role of Type 2 Inflammation in Skin Diseases
Dermatology
25 min
expert video

Shared and Distinct: The Role of Type 2 Inflammation in Skin Diseases

Time to Act: Reducing the Impact of Uncontrolled Disease Through Early Intervention
Dermatology
25 min
expert video

Time to Act: Reducing the Impact of Uncontrolled Disease Through Early Intervention

Mechanisms of Production and Clinical Impact of IgE
Pulmonology
5 min
videoanimation

Mechanisms of Production and Clinical Impact of IgE

Decoding the Clinical Puzzle: Navigating Diagnostic Complexity Across Inflammatory Skin Diseases
Dermatology
25 min
expert video

Decoding the Clinical Puzzle: Navigating Diagnostic Complexity Across Inflammatory Skin Diseases

Cracking the Code: Diagnosing and Managing Skin Diseases With Type 2 Inflammation
Dermatology
120 min
expert video

Cracking the Code: Diagnosing and Managing Skin Diseases With Type 2 Inflammation

Exploring the Mechanisms of FeNO Production in the Lungs
Pulmonology
4 min
videoanimation

Exploring the Mechanisms of FeNO Production in the Lungs

How Type 2 Inflammation Drives Eosinophils in Asthma
Pulmonology
4 min
videoanimation

How Type 2 Inflammation Drives Eosinophils in Asthma

    1234
    ...
    30